Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02157701 · ClinicalTrials.gov registry record · Phase 4
Polyherbal Capsule Formulation for Joint Health
A Phase 4 study, sponsored by NewChapter.
- Completed
- Registry status
- Phase 4
- Development phase
- 108
- Enrollment target
NCT02157701: Completed Phase 4 study, sponsored by NewChapter.
NCT02157701 is a Phase 4 study that has completed, run by NewChapter. The registered enrollment target is 108 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02157701, a Phase 4 study, has completed, sponsored by NewChapter.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 108 participants
- Enrollment target
Study Summary
This is a multicenter, randomized, double-blind, placebo-controlled, study in subjects with exercise-related knee pain/discomfort to determine the efficacy of a polyherbal capsule compared to placebo capsule in improving exercise capacity and overall parameters of joint health.
Primary Outcome
Subjects will walk up and down a hallway for 6 minutes after being instructed to walk as rapidly as possible within their comfort zone and without causing themselves any pain. Study personnel will time each subject with a stopwatch and measure the total distance travelled in the 6 minutes.
Interventions
- DIETARY_SUPPLEMENT Placebo capsule
- DIETARY_SUPPLEMENT Polyherbal capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-04 |
| Phase | Phase 4 |
What the finished NCT02157701 record still lists
NCT02157701 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo capsule is the first listed.
NCT02157701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02157701 about?
NCT02157701 is a clinical study titled "Polyherbal Capsule Formulation for Joint Health". This is a multicenter, randomized, double-blind, placebo-controlled, study in subjects with exercise-related knee pain/discomfort to determine the efficacy of a polyherbal capsule compared to placebo capsule in improving exercise capacity and overall parameters of joint health.
What is the current status of trial NCT02157701?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 108 participants. The study started on 2014-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02157701?
The interventions under investigation include: Placebo capsule (DIETARY_SUPPLEMENT), Polyherbal capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02157701?
This trial is sponsored by NewChapter, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02157701's enrollment target sits among peer trials
108 740th of 2000 higher than 1,256 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia